STOCK TITAN

Maravai LifeSciences Announces November 2021 Investor Conference Schedule

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Maravai LifeSciences (NASDAQ: MRVI) has announced its participation in two upcoming virtual investor conferences in November 2021. CFO Kevin Herde will engage in a fireside chat at the Stifel Healthcare Conference on November 17 at 10:20 a.m. PT and present at the Nasdaq Investor Conference on November 30 at 7:00 a.m. PT. Live webcasts will be available on the company's investor relations website, with archived versions posted shortly after each event. Maravai specializes in life science reagents and services, supporting drug therapy and diagnostics development.

Positive
  • Participation in two significant investor conferences, potentially increasing visibility among investors.
  • CFO Kevin Herde's presence at reputable events may enhance investor confidence in the company.
Negative
  • None.

SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of November.

On November 17, 2021, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Stifel Healthcare Conference at 10:20 a.m. PT.

On November 30, 2021, Kevin Herde, Chief Financial Officer, will present at the Nasdaq Investor Conference at 7:00 a.m. PT.

A live webcast of the presentations will be available to all interested parties on the Maravai Lifesciences investor relations website at http://investors.maravai.com. An archived version of the webcast will be available shortly after the completion of each event on the Maravai investor relations website.

About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologic safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. For more information about Maravai LifeSciences, visit www.maravai.com.


FAQ

What conferences will Maravai LifeSciences participate in November 2021?

Maravai LifeSciences will participate in the Stifel Healthcare Conference on November 17 and the Nasdaq Investor Conference on November 30, 2021.

Who is presenting for Maravai at the investor conferences?

Kevin Herde, the Chief Financial Officer, will present at both conferences.

Where can I watch the Maravai investor conference presentations?

The presentations will be available via live webcast on the Maravai investor relations website.

What is Maravai LifeSciences known for?

Maravai LifeSciences is known for providing critical life science products that support drug therapies, diagnostics, and vaccine development.

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Stock Data

776.59M
119.61M
1.37%
102.83%
4.91%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SAN DIEGO